Back
Perspective Therapeutics Stock Price Chart
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
30
CATX
Perspective Therapeutics
Last Price:
7.88
Seasonality Move:
40.67%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.48 | Sell |
| 20-day SMA: | 11.39 | Sell |
| 50-day SMA: | 12.61 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 10.03 | Sell |
| 20-day EMA: | 11.13 | Sell |
| 50-day EMA: | 12.15 | Sell |
| 200-day EMA: | 11.67 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 19.21 | Sell |
| Chaikin Money Flow: | -1814221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.47 - 12.81) | Sell |
| Bollinger Bands (100): | (11.15 - 14.37) | Sell |
Perspective Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 7.88 while CATX 8-day simple moving average is 10.48, which is a Sell signal.
- The stock price of CATX is 7.88 while Perspective Therapeutics 20-day SMA is 11.39, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 12.61 while CATX share price is 7.88, making it a Sell technically.
- CATX stock price is 7.88 and Perspective Therapeutics 200-day simple moving average is 12.80, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
531.33M
Price in USD:
7.88
Share Volume:
1.85M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.28
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 7.88 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 7.88 while CATX 8-day exponential moving average is 10.03, which is a Sell signal.
- The stock price of CATX is 7.88 while Perspective Therapeutics 20-day EMA is 11.13, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 12.15 while CATX share price is 7.88, making it a Sell technically.
- CATX stock price is 7.88 and Perspective Therapeutics 200-day simple moving average is 11.67, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -0.91, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 19.21, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (10.47 - 12.81), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (11.15 - 14.37), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.